These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26670723)

  • 61. Prediction of coronary artery disease in patients with lower extremity peripheral artery disease.
    Cho SW; Kim BG; Kim DH; Kim BO; Byun YS; Rhee KJ; Lee BK; Goh CW
    Int Heart J; 2015; 56(2):209-12. PubMed ID: 25740583
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease.
    Welten GM; Schouten O; Hoeks SE; Chonchol M; Vidakovic R; van Domburg RT; Bax JJ; van Sambeek MR; Poldermans D
    J Am Coll Cardiol; 2008 Apr; 51(16):1588-96. PubMed ID: 18420103
    [TBL] [Abstract][Full Text] [Related]  

  • 63. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
    Bangalore S; Steg G; Deedwania P; Crowley K; Eagle KA; Goto S; Ohman EM; Cannon CP; Smith SC; Zeymer U; Hoffman EB; Messerli FH; Bhatt DL;
    JAMA; 2012 Oct; 308(13):1340-9. PubMed ID: 23032550
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials.
    WAVE Investigators
    Am Heart J; 2006 Jan; 151(1):1-9. PubMed ID: 16368284
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Temporal trends, safety, and efficacy of bivalirudin in elective percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
    Gurm HS; Smith DE; Chetcuti SJ; Share D; Khanal S; Riba A; Carter AJ; Lalonde T; Kline-Rogers E; O'Donnell M; O'Neill W; Safian R; Moscucci M;
    J Interv Cardiol; 2007 Jun; 20(3):197-203. PubMed ID: 17524111
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation.
    Aguilar E; García-Díaz AM; Sánchez Muñoz-Torrero JF; Alvarez LR; Piedecausa M; Arnedo G; Monreal M;
    Thromb Res; 2012 Sep; 130(3):390-5. PubMed ID: 22658293
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Meta-analysis of the role of high-dose statins administered prior to percutaneous coronary intervention in reducing major adverse cardiac events in patients with coronary artery disease.
    Hao PP; Chen YG; Wang JL; Ji WQ; Xue L; Liu XH; Wang XL; Zhang Y
    Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):496-500. PubMed ID: 19930422
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study.
    Schlitt A; Rubboli A; Lip GY; Lahtela H; Valencia J; Karjalainen PP; Weber M; Laine M; Kirchhof P; Niemelä M; Vikman S; Buerke M; Airaksinen KE;
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E864-70. PubMed ID: 23765437
    [TBL] [Abstract][Full Text] [Related]  

  • 69. MULTInational non-interventional study of patients with ST-segment elevation myocardial infarction treated with PRimary Angioplasty and Concomitant use of upstream antiplatelet therapy with prasugrel or clopidogrel--the European MULTIPRAC Registry.
    Clemmensen P; Grieco N; Ince H; Danchin N; Goedicke J; Ramos Y; Schmitt J; Goldstein P;
    Eur Heart J Acute Cardiovasc Care; 2015 Jun; 4(3):220-9. PubMed ID: 25182465
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparative evaluation of socioeconomic insecurity in peripheral and coronary artery disease patients.
    Joly M; Gillois P; Satger B; Blaise S; Pernod G
    J Med Vasc; 2022; 47(5-6):220-227. PubMed ID: 36464416
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Supporting a call to action for peripheral artery disease: insights from two prospective clinical registries.
    Hackam DG; Tan MK; Lin PJ; Mehta PG; Jaffer S; Kates M; Oh M; Grima EA; Langer A; Goodman SG; ;
    J Vasc Surg; 2006 Oct; 44(4):776-81. PubMed ID: 16930931
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Epidemiology of peripheral artery disease in Europe: VAS Educational Paper.
    Olinic DM; Spinu M; Olinic M; Homorodean C; Tataru DA; Liew A; Schernthaner GH; Stanek A; Fowkes G; Catalano M
    Int Angiol; 2018 Aug; 37(4):327-334. PubMed ID: 29936722
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dietary intake and cardiovascular outcomes in patients with chronic vascular disease: insights from the COMPASS trial cohort.
    Wan D; Dehghan M; de Souza RJ; Ramasundarahettige C; Eikelboom JW; Bosch J; Maggioni AP; Bhatt DL; Yusuf S; Anand SS
    Eur J Prev Cardiol; 2023 Jun; 30(8):709-718. PubMed ID: 37080912
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Management and Outcomes Among Chinese Hospitalized Patients With Established Cardiovascular Disease or Multiple Risk Factors.
    Yang J; Yang Y; Gu H; Li W; Hu D
    Angiology; 2016 Feb; 67(2):168-73. PubMed ID: 25922196
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Factors Influencing the Prescription of Cardiovascular Preventive Therapies in Patients with Peripheral Arterial Disease.
    Montminy ML; Gauvin V; Turcotte S; Milot A; Douville Y; Bairati I
    PLoS One; 2016; 11(2):e0148069. PubMed ID: 26849679
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Increased Exercise Favorably Modifies Coronary Artery Disease and Peripheral Arterial Disease Outcomes.
    Whayne TF; Mukherjee D
    Curr Vasc Pharmacol; 2016; 14(5):458-465. PubMed ID: 27456103
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A Targeted Literature Review of the Disease Burden in Patients With Symptomatic Peripheral Artery Disease.
    Bauersachs R; Debus S; Nehler M; Huelsebeck M; Balradj J; Bowrin K; Briere JB
    Angiology; 2020 Apr; 71(4):303-314. PubMed ID: 31884807
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Vascular passport : a tool for secondary prevention among patients with peripheral artery disease].
    Keller S; Del Giorno R; Buso G; Deslarzes C; Calanca L; Lanzi S; Mazzolai L
    Rev Med Suisse; 2021 Dec; 17(762):2128-2131. PubMed ID: 34878740
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evidence-Based Recommendations for Medical Management of Peripheral Artery Disease.
    Golledge J; Drovandi A
    J Atheroscler Thromb; 2021 Jun; 28(6):573-583. PubMed ID: 33746159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.